ARCH Venture Fund XII, L.P. - Insider Non-Derivative Transactions at Prime Medicine, Inc. (PRME) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 15, 2024, ARCH Venture Fund XII, L.P.'s relationship to Prime Medicine, Inc. (PRME) is TenPercentOwner, and currently has 3,200,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PRME insiders.
Data Source: SEC.
ARCH Venture Fund XII, L.P. - Insider Non-Derivative Transactions at PRME
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 16, 2024 | P -- (Common Stock) | 3200000 | 6.25 | 3200000 |